肿瘤学: Preclinical, Clinical Trials & Post-Market

今年有超过五百万人的癌症会死亡;我们的使命是帮助您提高人们的健康和生活。从数百个临床前yaboapp体育官网pharmacology tumor modelsandcell line assays跑步oncology clinical trials & post-market studieson thousands of patients in dozens of countries, we can help you get your next breakthrough cancer drug orprecision medicine treatment那些拼命需要的人。

肿瘤学已成为药物开发中最多的研究密集型治疗区域。你需要一个以患者为中心的CRO合作伙伴,他们每一次旅程都可以成为你的一步。

  • Embrace a personalized medicine approach that targets therapies to specific subsets of patients and begins in the preclinical phase of drug development
  • Utilizebiomarkersin clinical oncology development to provide key data for earlier decision making as well as patient and site selection
  • Co-develop drug with anoncology companion diagnostics identifiesto help identify patients most likely to benefit from your next cancer breakthrough
网络研讨会系列:在肿瘤学中的精密药物应用

临床试验& Testing

  • In the last five years, Covance’s expertise, insights and market impact have been demonstrated in excess of975肿瘤学研究(300 in immuno-oncology) across nearly 19,000 sites in 83 countries with more than 104,000 oncology patients.

  • 患者招聘的数据驱动和生物标志物选择

肿瘤学Diagnostics

特色筛选和诊断测试:

  • omn​​iseq.
  • Intelligen®Myeloid.
  • PD-L1测试

Preclinical Immunotherapy

The industry has approachedimmuno-oncology从许多角度来看,需要识别,开发和改进能够与相关和相关终点一起重新构建最佳生物动态的模型。

精密药& Clinical Trials

获得收益临床试验的精密药物需要新方法快速测试d target the right therapy to the right individual. In addition to dozens of late-stageimmuno-oncology clinical trials,我们也支持超过70%的人FDA批准的伴侣诊断产品

亲吻她的朋友的额头的妇女

肿瘤学Educational Resources

We look forward to meeting you at a number ofoncology and immunology events今年。